• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
N/A
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
539,941 | 2009-06-24 | 0 | |
|
6,172 | 2009-06-19 | 0 | |
|
1,300 | 2009-06-19 | 0 | |
|
747,140 | 2009-06-04 | 0 | |
|
3,492,494 | 2009-03-24 | 0 | |
|
SHEFFIELD DEBORAH L. VP-CLINICAL®ULATORY AFFAIRS |
|
31,652 | 2009-03-11 | 0 |
|
DOW BRIAN B VP-FINANCE, CFO, SECRETARY |
|
13,364 | 2009-03-11 | 0 |
|
GANI MATTHEW VICE PRESIDENT, PRODUCT DEV |
|
11,663 | 2009-02-04 | 0 |
|
CALVERT RAYMOND N VP, FINANCE AND CFO |
|
19,149 | 2008-12-01 | 0 |
|
3,733,926 | 2008-11-18 | 0 | |
|
0 | 2008-06-16 | 0 | |
|
0 | 2008-06-16 | 0 | |
|
0 | 2008-06-16 | 0 | |
|
0 | 2008-06-16 | 0 | |
|
3,265,400 | 2008-04-02 | 0 | |
|
2,933,734 | 2008-04-02 | 0 | |
|
MEHTA NAWZER VP CLINICAL AFFAIRS |
|
16,800 | 2008-04-01 | 0 |
|
GLINER BRADFORD E VP RESEARCH |
|
42,883 | 2008-04-01 | 0 |
|
LYNCH SCOTT VP MKTING & BUSINESS DEV. |
|
16,800 | 2008-04-01 | 0 |
|
0 | 2007-07-24 | 0 | |
|
10,000 | 2007-06-15 | 0 | |
|
31,921 | 2007-05-18 | 0 | |
|
MAYFIELD X MANAGEMENT LLC MAYFIELD X ANNEX A DELAWARE LP MAYFIELD X ANNEX MANAGEMENT LLC MAYFIELD ASSOCIATES FUND IV L P MAYFIELD PRINCIPALS FUND LLC |
|
2,335,934 | 2007-05-15 | 0 |
|
2,335,934 | 2007-05-15 | 0 | |
|
RAY JOHN M VP-PRODUCT QUALITY & OPERATION |
|
10,000 | 2007-01-16 | 0 |
|
PETERSON AMY VP-REG AFFAIRS & QUAL ASSURANC |
|
0 | 2006-11-27 | 0 |
|
3,333 | 2006-05-04 | 0 | |
|
3,333 | 2006-05-04 | 0 | |
|
0 | 2006-05-04 | 0 | |
|
0 | 2006-05-04 | 0 | |
|
3,333 | 2006-05-04 | 0 | |
|
3,333 | 2006-05-04 | 0 | |
|
3,333 | 2006-05-04 | 0 | |
|
3,333 | 2006-05-04 | 0 | |
|
3,333 | 2006-05-04 | 0 | |
|
GLASTETTER LORI J VP-REGULATORY&QUAL ASSURANCE |
|
243,103 | 2006-05-04 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
